INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of February 11, 2026, INO stock price declined to $1.61 with 1,343,946 million shares trading.

INO has a beta of 1.21, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.06 to the broad based SPY ETF.

INO has a market cap of $110.61 million. This is considered a Micro Cap stock.

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.44 earnings per share. This fell short of revenue expectation by $-8,330 and exceeded earnings estimates by $.05.

In the last 3 years, INO traded as high as $19.20 and as low as $1.30.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC.

INO has underperformed the market in the last year with a return of -16.1%, while the SPY ETF gained +15.6%. In the last 3 month period, INO fell short of the market, returning -25.1%, while SPY returned +1.8%. However, in the most recent 2 weeks INO has outperformed the stock market by returning +5.2%, while SPY returned -0.5%.

INO support price is $1.62 and resistance is $1.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.